Brief: CVRx® Receives MR-Conditional Labeling Approval For Its Barostim™ Heart Failure System
09/05/2022 14:15
May 9 (Reuters) - CVRx Inc CVRX.O :
* CVRX® RECEIVES MR-CONDITIONAL LABELING APPROVAL FOR ITS
BAROSTIM™ HEART FAILURE SYSTEM
Source text for Eikon: ID:nGNX4lDmy3
Further company coverage: CVRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CVRx
See all newsBrief: CVRx Announces Humana Medicare Advantage Coverage Policy For Barostim Therapy
CVRx's Q1 revenue rises 20%, beats expectations
Brief: CVRx Q1 Revenue USD 14.769 Million Vs. IBES Estimate USD 14.5 Million
CVRx preliminary Q1 revenue rises 20%, gross margin improves
CVRx Q4 revenue rises 4%, beats expectations